中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2012年
19期
2917-2918
,共2页
超声检查%子宫瘢痕妊娠%介入治疗%甲氨蝶呤
超聲檢查%子宮瘢痕妊娠%介入治療%甲氨蝶呤
초성검사%자궁반흔임신%개입치료%갑안접령
Ultrasound examination%Uterine scars pregnancy%Intervention%Methotrexate
目的 比较经阴道超声引导下甲氨蝶呤介入治疗与肌内注射治疗子宫瘢痕妊娠的临床疗效. 方法 子宫瘢痕妊娠患者22例分为两组,A组(n=12)经阴道彩超引导下穿刺介入治疗;B组(n=10)用甲氨蝶呤肌内注射治疗,比较术前和术后4d、7d及1个月包块大小变化及血绒毛膜促性腺激素(β-HCG)变化.结果 甲氨蝶呤介入治疗与肌内注射治疗子宫瘢痕妊娠的治愈率分别为83.3%和40.0%,差异有统计学意义(P<0.05).结论 经阴道彩超引导下介入注射甲氨蝶呤较肌内注射甲氨蝶呤治疗子宫瘢痕妊娠疗效更好.
目的 比較經陰道超聲引導下甲氨蝶呤介入治療與肌內註射治療子宮瘢痕妊娠的臨床療效. 方法 子宮瘢痕妊娠患者22例分為兩組,A組(n=12)經陰道綵超引導下穿刺介入治療;B組(n=10)用甲氨蝶呤肌內註射治療,比較術前和術後4d、7d及1箇月包塊大小變化及血絨毛膜促性腺激素(β-HCG)變化.結果 甲氨蝶呤介入治療與肌內註射治療子宮瘢痕妊娠的治愈率分彆為83.3%和40.0%,差異有統計學意義(P<0.05).結論 經陰道綵超引導下介入註射甲氨蝶呤較肌內註射甲氨蝶呤治療子宮瘢痕妊娠療效更好.
목적 비교경음도초성인도하갑안접령개입치료여기내주사치료자궁반흔임신적림상료효. 방법 자궁반흔임신환자22례분위량조,A조(n=12)경음도채초인도하천자개입치료;B조(n=10)용갑안접령기내주사치료,비교술전화술후4d、7d급1개월포괴대소변화급혈융모막촉성선격소(β-HCG)변화.결과 갑안접령개입치료여기내주사치료자궁반흔임신적치유솔분별위83.3%화40.0%,차이유통계학의의(P<0.05).결론 경음도채초인도하개입주사갑안접령교기내주사갑안접령치료자궁반흔임신료효경호.
Objective To investigate the efficiency of interventional treatment and intramuscular injection of methotrexate for the treatment uterine scar pregnancy.Methods 22 patients with uterine scar pregnancy were divided into two groups,group A (n =12),transvaginal color Doppler ultrasound to guide percutaneous interventional treatment;group B( n =10) intramuscular injection of methotrexate treatment.Mass size and β-HCG preoperation and 4 days,7 days,1 month postoperation were evalutaed respectively.Results The cure rate of interventional treatment and intramuscular injection of methotrexate for the treatment uterine scar pregnancy were 83.3% and 40.0% respectively.And the difference was statistically significant ( P < 0.05 ).Conclusion Compared with intramuscular methotrexate treatment of uterine scar pregnancy,guided by vaginal ultrasonography involved the injection of methotrexate is more effective and have important clinical significance.